Emmanuel Chartier‐Kastler

BOTULINUM TOXIN TYPE A IS A SAFE AND EFFECTIVE TREATMENT FOR NEUROGENIC URINARY INCONTINENCE: RESULTS OF A SINGLE TREATMENT, RANDOMIZED, PLACEBO CONTROLLED 6-MONTH STUDY

Brigitte Schurch, Marianne de Sèze, P. Denys et al. · The Journal of Urology · 2005 · 579 citations

Medicine, Pharmacotherapy, Urology +17

European Experience of 200 Cases Treated with Botulinum-A Toxin Injections into the Detrusor Muscle for Urinary Incontinence due to Neurogenic Detrusor Overactivity

André Reitz, Giulio Del Popolo, Emmanuel Chartier‐Kastler et al. · European Urology · 2003 · 396 citations

Medicine, Surgery, Urology +17

Sacral Neuromodulation: Standardized Electrode Placement Technique

Klaus E. Matzel, Emmanuel Chartier‐Kastler, Charles H. Knowles et al. · Neuromodulation Technology at the Neural Interface · 2017 · 188 citations

Medicine, Neurological Surgery, Neurosurgery +14

Urinary Incontinence in French Women: Prevalence, Risk Factors, and Impact on Quality of Life

Andréa Lasserre, Camille Pelat, Violaine Guéroult et al. · European Urology · 2009 · 183 citations

Medicine, Urology, Female Urology +15

International Continence Society best practice statement for use of sacral neuromodulation

Howard B. Goldman, Jessica C. Lloyd, Karen Noblett et al. · Neurourology and Urodynamics · 2018 · 173 citations · Full text

Medicine, Neuroscience, Neurosurgery +12